The U.S. Department of Health and Human Services (HHS) has awarded Moderna $590 million to expedite clinical trials and enhance manufacturing capabilities for a vaccine against avian influenza, commonly known as bird flu. This funding aims to bolster preparedness for potential future outbreaks of the virus in humans.
Tag: HHS
Moderna Granted $590M to Advance mRNA-based Avian Flu Vaccine Development
The US Department of Health and Human Services (HHS) has provided Moderna with a $590 million investment to hasten the development of an mRNA-based avian flu vaccine. This move aims to bolster global preparedness in case of a potential pandemic caused by the lethal bird flu virus.